March 19, 2022
The FDA tonight approved a combination nivolumab/relatlimab-rmbw immune checkpoint inhibitor (Opdualag) for unresectable or metastatic melanoma in adults and children 12 years or older, according to […]
March 16, 2022
The US Food and Drug Administration (FDA) approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol for the treatment of asthma in […]
March 15, 2022
The US Food and Drug Administration (FDA) has approved donepezil transdermal system (Adlarity) for patients with mild, moderate, or severe Alzheimer’s disease (AD), the manufacturer has […]
March 14, 2022
The US Food and Drug Administration (FDA) has issued a warning about the off-label use of the Renuvion/J-Plasma device for dermal resurfacing and skin contraction procedures. […]
March 14, 2022
The PARP inhibitor olaparib (Lynparza) is now approved by the US Food and Drug Administration (FDA) for use in early-stage breast cancer as well as later-stage […]
March 11, 2022
The US Food and Drug Administration has approved a new contact lens that elutes the antihistamine ketotifen as a treatment for ocular allergy. “This is the […]
March 10, 2022
The US Food and Drug Administration has approved a novel plasma collection device designed to meet the rapidly increasing demand for human plasma-based therapies. The Rika […]
March 9, 2022
Medtronic has recalled 686 TurboHawk Plus Directional Atherectomy Systems because there is a risk that the guidewire within the catheter may move downward or prolapse during […]
March 5, 2022
The US Food and Drug Administration (FDA) has approved nivolumab for neoadjuvant treatment of non-small cell lung cancer (NSCLC) in combination with platinum-doublet chemotherapy, regardless of […]